Free Trial
NASDAQ:PHXM

PHAXIAM Therapeutics (PHXM) Stock Price, News & Analysis

PHAXIAM Therapeutics logo
$3.10 0.00 (0.00%)
As of 07/11/2025

About PHAXIAM Therapeutics Stock (NASDAQ:PHXM)

Key Stats

Today's Range
$3.10
$3.10
50-Day Range
$3.10
$3.10
52-Week Range
$2.50
$13.00
Volume
N/A
Average Volume
2,472 shs
Market Capitalization
$10.58 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PHXM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PHAXIAM Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

PHXM Stock News Headlines

Forget Nvidia, This “Ghost Town” Company Holds the Key to the AI Boom
Cold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to investigate this crazy Cold War story… Because it could hold the key to the entire $100 trillion AI boom. It involves an American ghost town with just 30 people… And a new twist to the AI boom that could make a lot of people rich.
See More Headlines

PHXM Stock Analysis - Frequently Asked Questions

PHAXIAM Therapeutics' stock was trading at $3.10 at the beginning of 2025. Since then, PHXM shares have increased by 0.0% and is now trading at $3.10.

Shares of PHAXIAM Therapeutics reverse split on Wednesday, September 20th 2023.The 1-10 reverse split was announced on Wednesday, September 20th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, September 20th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Shares of PHXM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that PHAXIAM Therapeutics investors own include Salesforce (CRM), AbbVie (ABBV), Bank of America (BAC), Chevron (CVX), Merck & Co., Inc. (MRK), The PNC Financial Services Group (PNC) and AGCO (AGCO).

Company Calendar

Today
7/15/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:PHXM
CIK
1624422
Employees
49
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
0.23
Current Ratio
1.78
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$7.98 per share
Price / Book
0.39

Miscellaneous

Outstanding Shares
3,412,000
Free Float
3,346,000
Market Cap
$10.58 million
Optionable
No Data
Beta
2.35
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:PHXM) was last updated on 7/15/2025 by MarketBeat.com Staff
From Our Partners